Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver
- 90 Downloads
Attempts at identifying prognostic factors after hepatectomy in patients with colorectal liver metastases have not achieved consensus. We investigated prognostic factors ascertainable before hepatectomy for colorectal metastasis.
Clinicopathological data for 149 consecutive patients with colorectal cancer who underwent curative resection of primary lesions and metastatic liver disease at one institution were subjected to multivariate analysis concerning metastatic status and the primary lesion.
Poorly differentiated adenocarcinoma or mucinous carcinoma as the primary tumor (Poor/muc; P=0.026), marked vascular invasion by the primary tumor (V; P=0.002), bi-lobar liver metastases (P=0.048), and short doubling time (DT) of the liver tumor (P=0.028) were characteristics assessable before hepatectomy that independently indicated poorer survival. A four-stage classification based on these factors was related to overall (P<0.01) and disease-free (P<0.01) survival rates. No pattern of recurrence site was evident in stage I (patients with no risk factor). Recurrence was usually extrahepatic in stage IV (patients with Poor/muc) but favored the remnant liver in stage II (patients with bi-lobar metastases or short DT) or III (patients with V; P=0.037). Stage III showed more multiple and early hepatic recurrences than stage II, and repeat hepatectomy was less frequent (P<0.05).
Pre-hepatectomy prognostic staging should help to guide treatment of liver metastases.
KeywordsColorectal cancer Liver metastasis Hepatectomy Prognostic factor Staging
- 6.Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Levi F (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663–669CrossRefPubMedGoogle Scholar
- 10.Collins VP, Loeffier RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol 76:988–1000Google Scholar
- 13.Fujii S (1994) Hepatic metastases development from colorectal cancer in view of CEA doubling time (in Japanese with English abstract). Yokohama Igaku 45:627–635Google Scholar
- 14.Shimada H, Nanko M, Fujii S, Masui H, Togo S, Ike H, Nakano A, Ohki S (1995) Treatment strategies for hepatic metastasis from colorectal cancer. J Hepatobiliary Pancreat Surg 2:116–121Google Scholar
- 15.Japanese Society for Cancer of the Colon and Rectum (1997) Japanese classification of colorectal carcinoma, 1st English edn. Kanehara, TokyoGoogle Scholar
- 29.Deans GT, Patterson CC, Parks TG, Spence RA, Heatley M, Moorehead RJ, Rowlands BJ (1994) Colorectal carcinoma: importance of clinical and pathological factors in survival. Ann R Coll Surg Engl 76:59–64Google Scholar
- 32.Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, Mochizuki H, Yamamoto J (2003) Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46 [10 Suppl]:S22–31PubMedGoogle Scholar
- 35.Bismuth H, Castaing D, Traynor O (1988) Surgery for synchronous hepatic metastases of colorectal cancer. Scand J Gastroenterol 149:144–149Google Scholar
- 36.Griiffith KD, Sugarbaker PH, Chang AE (1990) Repeat hepatic resection for colorectal metastases. Surgery 81:101–104Google Scholar
- 37.Panis Y, Ribeiro J, Chretien Y, Nordlinger B (1994) Dormant liver metastases: an experimental study. Br J Surg 19:221–233Google Scholar